3 Secrets to Minimizing High-Cost Products on Your Formulary

An important part of limiting spend is helping members avoid high cost products when equally effective generic alternatives exist.

If you’re a plan sponsor, chances are that you have your hands full working to keep pharmacy costs manageable for your organization and your employees. With over 20,000 prescription drugs currently approved for marketing by the FDA, deciding which drugs to cover can be a challenge.1 Unfortunately, a number of market events can lead to scenarios where even small shifts in utilization can result in large cost increases for plans. Having a PBM partner with the tools and experience necessary to address these scenarios when they occur is imperative for every plan sponsor.

Here are three examples of such market events and how we responded to keep plan costs low.

Secret #1: SET THE STAGE FOR UPCOMING GENERICs

Generic medications are chemically identical to their brand-name counterparts, but can offer significant savings. However, it can be difficult for plan sponsors to take advantage of the launch of a new generic if members are already using a number of similar products. In the case of Lyrica®, a nerve pain medication that can also be used to treat seizures, an extended release formulation (Lyrica® CR) was launched in 2018, a year before the generic alternative became available. Allowing members to switch to the new formulation in the short term would make it more costly and difficult to move them to the generic later. By keeping Lyrica® CR off the formulary and having almost no utilization at the time the generic launched, plan sponsors were better able to take advantage of the cost-savings associated with the generic when it became available in 2019.

SECRET #2: Protect Your Plan from “New” Products Identical to Generics

Some high-cost products claim to be new, but differ only minimally from existing generics, such as in dosage strength. For instance, Aplezin™, an extended release bupropion product, can cost over $1,000 per claim. In contrast, other generic extended release bupropion products are available for less than $20 per month. In these cases, a handful of members using the more expensive formulation can have a major impact on plan spend. A lowest-net-cost formulary strategy prevents this by covering only the less-expensive, but clinically equivalent alternative.

SEcret #3: Block Unnecessarily Repackaged Vitamins

A popular practice in recent years is packaging several common vitamins together into a high-cost “pack.” Far more expensive than separately packaged vitamins, these can drive up plan costs by thousands of dollars per claim. A proactive approach to blocking these is important, as some pharmacies will use them to generate additional revenue at the plan’s expense. Plan sponsors can shield themselves from these unnecessary costs by identifying these products and excluding them from their formularies.

Want to learn more about ways to reduce your costs? Download our 2019 Drug Trend Report today! It’s loaded with cost management strategies that can help get your Rx benefits headed in the right direction.

Fact Sheet: FDA at a Glance. U.S. Food and Drug Administration. https://www.fda.gov/about-fda/fda-basics/fact-sheet-fda-glance. Updated October 18, 2019. Accessed June 3, 2020.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Examining Trends that Drive Informed Decisions

Now Available: 8th Annual Drug Trend Report

See the latest results and access industry insights you need to navigate current trend drivers.

Related blogs

Navigating Healthcare and Improving Outcomes

Achieving Outstanding Results with Tailored Network Strategies

Achieving Outstanding Results with Tailored Network Strategies

A medium-sized city in Michigan with 1,350 members was seeking ways to lower its pharmacy benefit costs, which were growing under its existing traditional pharmacy benefit manager (PBM). With its member covered by a two-tier, open formulary including…

Breaking Through Barriers with Value-Based Plan Design

Breaking Through Barriers with Value-Based Plan Design

Facing increased pharmacy benefit expenses, Blain’s Farm and Fleet, a Midwestern employer group, desired to improve plan performance. Specifically it was interested in educating eligible members about the benefits available to them, promoting cost-effective…

Finding a Solution to Lower Prescription Drug Costs

Finding a Solution to Lower Prescription Drug Costs

The Rural Arizona Group Health Trust (RAGHT) wanted to gain better control of its escalating drug trend with its large, traditional pharmacy benefit manager (PBM). Having only worked with traditional PBMs in the past, RAGHT was interested in exploring…

Empowered by Strategic Opportunities and Service Excellence

Empowered by Strategic Opportunities and Service Excellence

Putnam | Northern Westchester Health Benefits Consortium (PNW HBC) was the first municipal cooperative health plan in the state of New York to become certified by the Department of Insurance. They are dedicated to meeting — and exceeding — the standards…

QUALYiQ Program Delivers Significant Savings for Both Members and Health Plans

QUALYiQ Program Delivers Significant Savings for Both Members and Health Plans

As part of their treatment plan for hypophosphatasia (HPP), a rare genetic disorder affecting bone and teeth development, one of our members required Strensiq, a medication designed to manage HPP. However, Strensiq’s annual treatment costs ranged from…

RISE: Reporting and Intervention for Stars Excellence

RISE: Reporting and Intervention for Stars Excellence

RISE is a comprehensive Star Ratings Improvement program that focuses on positive outcomes for Medicare Part D (Part D) clinical measures, including: medication adherence for diabetes medications, medication adherence for hypertension, medication adherence…

Medication Therapy Management: Improving Health Outcomes and Reducing Cost

Medication Therapy Management: Improving Health Outcomes and Reducing Cost

Patients with chronic diseases can face greater risks for medication-related challenges such as non-adherence. This can lead to poor health outcomes and higher plan costs. That’s why we developed an MTM program, offered through our Clinical Engagement…

Personalized Member Transitions: Creating a Smoother Benefit Transition

Personalized Member Transitions: Creating a Smoother Benefit Transition

Navigating benefit transitions is no easy task. Our personalized member transition (PMT) program makes it smoother for both plan sponsors and members. Through our high-touch outreach to members, we eliminate gaps in care, minimize member disruption, improve…

Pharmacy and Practitioner Exclusions and How to Resolve Them

Pharmacy and Practitioner Exclusions and How to Resolve Them

Prescribers and Pharmacies can be deemed ineligible for providing services to government programs like Medicare, Medicaid or even to payers who are participating in government programs. Being ineligible to provide those services is commonly referred to…

previous arrow
next arrow